KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Payables (2016 - 2026)

Teladoc Health's Payables history spans 13 years, with the latest figure at $45.2 million for Q1 2026.

  • On a quarterly basis, Payables fell 13.17% to $45.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $45.2 million, a 13.17% decrease, with the full-year FY2025 number at $48.0 million, up 44.78% from a year prior.
  • Payables hit $45.2 million in Q1 2026 for Teladoc Health, down from $48.0 million in the prior quarter.
  • Over the last five years, Payables for TDOC hit a ceiling of $94.4 million in Q2 2022 and a floor of $16.1 million in Q2 2023.
  • Historically, Payables has averaged $47.1 million across 5 years, with a median of $47.4 million in 2022.
  • Biggest five-year swings in Payables: crashed 82.97% in 2023 and later surged 249.14% in 2024.
  • Tracing TDOC's Payables over 5 years: stood at $47.7 million in 2022, then decreased by 8.5% to $43.6 million in 2023, then fell by 24.08% to $33.1 million in 2024, then skyrocketed by 44.78% to $48.0 million in 2025, then decreased by 5.78% to $45.2 million in 2026.
  • Business Quant data shows Payables for TDOC at $45.2 million in Q1 2026, $48.0 million in Q4 2025, and $52.2 million in Q3 2025.